Table III.
Evidence of the effects of melatonin on osteoarthritis in animal studies.
Refs. | Objectives | Model | Route of administration | Time of administration | Frequency | Doses | Duration | Outcomes |
---|---|---|---|---|---|---|---|---|
82 | C57BL/6J mice | Surgically-induced osteoarthritis | Intra-articular injection | After surgery | Twice a week | 10 mg/ml (10 µl) | 4 weeks | Attenuated OA progression |
87 | New Zealand white rabbits (female) | Surgically-induced osteoarthritis | Intra-articular injection | Beginning on the day of surgery | Weekly | 20 mg/kg | 4 weeks | Reduced cartilage degradation |
88 | Lewis rats | Surgically-induced osteoarthritis | Intra-articular injection | On day 3 following the surgery | Once | 10 mg/ml (20 µl) | - | Repressed expression of relevant genes in rat OA pathogenesis after 3 weeks |
95 | Sprague-Dawley rats | Intra-articular collagenase injection- induced osteoarthritis | Subcutaneous injection | - | Twice daily | 10 mg/kg | 4 weeks | Melatonin prevented periarticular muscle damage and cartilage degeneration. But prolonged melatonin administration leaded to subchondral bone erosion |
112 | Sprague Dawley rats | Intra-articular collagenase injection- induced osteoarthritis | Subcutaneous injection | 07:00 and 19:00 | Twice daily | 10 mg/kg | 1, 4 weeks | Melatonin with treadmill exercise may have both preventive and synergistic effects on rescue from cartilage degeneration and is more effective in the initial phase (1 week) |